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ABSTRACT  A  high  molecular  weight  fraction  of a  soluble  Marsh  muscle- 
relaxing  preparation  has  been  shown  to  contain  a  calcium-complexing sub- 
stance. By examining the nature of the competition between this fraction and 
chelex-100 for calcium at various total calcium concentrations it has been possi- 
ble to calculate the concentration and calcium stability constant of this calcium- 
complexing substance.  Taking  into account dilutions which  occur during the 
preparation of fractions containing this substance its concentration may be esti- 
mated at about 2.10  -4 in muscle and its calcium stability constant was found 
to be about 1.5.105 ~f-1. Preliminary evidence suggests that the calcium-binding 
substance is a  protein. 
The Marsh skeletal muscle-relaxing factor indirectly produces relaxation I by 
the withdrawal  of calcium from the contractile mechanism  (1-3).  It is, there- 
fore,  of considerable  interest  and  importance  to  know which  constituents  of 
Marsh  factor preparations  influence calcium  concentration  and  the  mecha- 
nisms  by which  they accomplish  this  effect.  Many  of the  early experiments 
(4-7)  attempting  to  identify  the  material  from  skeletal  muscle  involved  in 
producing relaxation indicated that the relaxation activity resided exclusively 
with  the  microsome fraction.  This  is  true,  however,  only when  ATP  is  the 
energy source for calcium  uptake.  Weber  et  al.  (8)  have  shown  that  muscle 
mitochondria,  in  the  presence of succinate,  can  also decrease calcium  to the 
level of 10  .7 to  10  .6 u  Ca ~+,  the range  of calcium concentrations which are 
limiting for contraction. 
The claim that there are soluble substances in skeletal muscle homogenates 
which can influence actomyosin activity (9-11) in a  calcium reversible manner 
appears  controversial.  Doubts  about  the  validity  of  this  contention  have 
arisen  because  the  earlier  evidence  (12-14)  that  skeletal  muscle  microsomes 
1  The term relaxation is used to denote a cessation, which is calcium reversible, of such contractile- 
like phenomena as ATP induced or dependent syneresis, ATPase activity or tension generation in 
actomyosin containing preparations. Relaxation factors thus differ from the numerous list of sub- 
stances which can modify the activity of actomyosin preparations by being inactivated by calcium. 
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produce  a  soluble inhibitor of actomyosin activity has  been shown  by Seidel 
and  Gergely  (15)  to  be  fallacious.  This  fallacy  arose,  in  part,  because  the 
actomyosin system is sensitive to calcium lack independent of the mechanism 
of its genesis.  In the report that follows a  resin system has been developed to 
test whether the soluble fractions of skeletal muscle homogenates which relax 
actomyosin  preparations  are  simply  calcium  deficient  or  whether  they con- 
tain,  in  addition,  substances  capable  of binding  calcium.  By the  use  of this 
resin  system  evidence  has  been  obtained  for  such  a  calcium-binding  sub- 
stance.  Furthermore,  it has  been  possible  to  show that  the  calcium stability 
constant  of  the  calcium  complex  formed  with  this  substance  is  sufficiently 
large to effect the sequestration of significant amounts of calcium and to bring 
ionic  calcium  concentrations  into  the  range  required  for the  control of con- 
traction. 
EXPERIMENTAL  PROCEDURES 
Preparation of Muscle Fractions 
Rabbit hind leg muscle, 230 gin, was chilled in ice and homogenized for 1 minute in 
700 ml of solution  II  (see below).  This and  all  subsequent  preparative procedures 
were carried out in a  cold room at approximately 5°C. Myofibrils, debris, and mito- 
chondria were removed by centrifugation at 8000 g for 20 minutes. The supernatant 
from this fractionation was filtered through cheesecloth and centrifuged at 35,000 g 
for 70 minutes. The material in this pellet, constituting the heavy microsome fraetion, 
was  suspended  in  a  volume of solution II  equal to one-tenth of the volume of the 
35,000 g  supernatant.  The  35,000 g  supernatant  was  centrifuged at  198,000 g  for 
60 minutes.  The supernatant  was  carefully removed with  a  Pasteur pipet and  the 
pellet  disearded.  The  198,000 g  supernatant  served  as  starting  material  for  three 
preparations,  P-l,  P-2,  and  P-3. 
P-1 : 100 ml of 198,000 g supernatant, 2.5 ml of heavy mierosomes and 0.4 mmoles 
of ATP were incubated together at room temperature for 10 minutes and then sub- 
jected to  centrifugation,  198,000 g,  for 60 minutes.  This step  was  introduced  to 
remove  traces  of calcium  from the  muscle fraction.  The  supernatant  from this 
centrifugation was then fractionated on a  sephadex G-25 column (50  X  350 ram) 
equilibrated with solution I. The non-retarded fraction constitutes preparation P-1. 
P-2: This preparation was made in a  manner identical to that for P-1 except that 
the sephadex G-25 column was equilibrated with solution II. 
P-3 : To make this preparation the sequence of steps was reversed so that  100 mi of 
198,000 g  supernatant was first run on a  sephadex G-25 column equilibrated with 
solution II. The non-retarded fraction from the sephadex column was  brought to 
room temperature, heavy microsomes and ATP were added, the mixture incubated 
for 10 minutes, and then centrifuged at 198,000 g for 60 minutes. The supernatant 
from this centrifugation constitutes preparation P-3. F.  N.  BRIGGS AND  M.  FLEISHMAN Soluble  Calcium-Binding Substance in Muscle  i33 
Calcium-45 Binding 
The presence of soluble calcium-binding substances was detected by their sequestra- 
tion of Ca  45 which would otherwise have been bound to chelex-100. The method is 
similar to  that  used  by  Schubert (16)  to  determine  stability  constants  except that 
the metal concentration has been varied rather than the chelator concentration. This 
has allowed the determination of both the concentration and stability constant of the 
calcium-binding  substance.  The  chelex-100  was  washed  thoroughly  in  1  M HC1, 
brought to pH 6.7 with KOH, equilibrated with  1 M MgC12, washed extensively with 
distilled water, and equilibrated by extensive washing with solution I  or II depending 
upon the experiment. The chelex-100 was equilibrated with solution II when used 
to test the calcium-binding activity of P-3  or P-2 and with solution I  when used to 
test P-1. The chelex-100, 0.5 or I ml, was pipeted from a  constantly stirred reservoir 
into  12 ml conical centrifuge tubes. The resin was allowed to settle and the solution 
in which it was suspended was removed with a  Pasteur pipet. The sedimented resin 
volume, which is indicated for each experiment, was either 0.13 or 0.26 ml. Five ml 
of P-l, P-2, or P-3 containing 0.3 ~  of Ca  45 and varying amounts of Ca  4° were added 
to the centrifuge tubes containing chelex-100 and vigorously stirred for  15 seconds. 
The resin was then sedimented in a clinical centrifuge. A 0.5 ml sample of the super- 
natant was removed and its content of radioactivity measured by liquid scintillation 
using a Packard liquid scintillation spectrometer. 
Solutions 
The following solutions are defined: 
Solution I;  50 mM KC1, 30 mM imidazole 4  mM MgC12,  pH 6.7, 
Solution II; solution I  with  1 mM potassium oxalate, pH 6.7, 
Solution III; solution II with  4  mM ATP, pH 6.7. 
Reagents 
Sephadex G-25 was obtained from Pharmacia,  Upsala,  Sweden. The disodium salt 
of ATP was obtained from General Biochemicals Incorporated. Chelex-100 resin was 
purchased from California Corporation for Biochemical Research.  The imidazole is 
a  product  of Eastman  Kodak  Company.  The  EGTA,  2 a  gift  of Geigy  Chemical 
Corporation,  New York,  New York,  was  standardized  by titration against  calcium 
using calcein (17) as indicator and a  Turner fluorometer to follow the titration. 
RESULTS 
Fig.  1 shows that the percentage of non-resin bound Ca 45 is increased markedly 
by  the  presence  of the  known  calcium  chelator  EGTA  and  fortuitously  to 
almost the same extent by muscle preparation P-3, which was being tested for 
the  presence  of a  soluble  calcium-binding  substance.  The  control  solution, 
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which was prepared,  see legend to Fig.  1, in the manner  used to produce the 
hypothetical soluble relaxing factor  (12)  showed no evidence of the presence 
of a  calcium-binding  substance,  for  the  percentage  of Ca  4~  bound  to  resin 
remained constant over the complete range of calcium concentrations studied. 
This  nearly  constant  distribution  of Ca  45 was  expected since  the  concentra- 
tion  of resin  calcium-binding  sites  (approximately  1.2.10  -2 M,  see later  sec- 
tion)  was  considerably higher  than  all  calcium  concentrations  studied.  The 
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FIOURE 1.  Influence of EGTA and  the soluble muscle fraction P-3 on the binding of 
Ca  45 to chelex-100. Conditions of assay: 50 rnM KC1,  30 naM imidazole, 4 n~  MgCI~, 4 
mM ATP,  1 rau K  oxalate, 0.96 ml chelex-100, pH 6.7,  total volume 5.96  ml. Curve A 
illustrates Ca  4s binding in the control solution. This solution was prepared by incubating 
solution III at room temperature with heavy microsomes (0.95 ml/10 ml of solution III) 
for 10 minutes and then centrifuging the mixture at 198,000  g for 60 minutes. Curve C, 
a  solution identical to that shown in curve A,  except that EGTA was added  to give a 
concentration of 4.2.10  -5 M. Curve B, muscle preparation P-3. 
presence  of the  calcium  sequestering  agents,  EGTA  and  P-3,  was  most  ap- 
parent  at low calcium concentrations  where they competed successfully with 
the resin  for  Ca  45.  As the calcium  concentration  was raised  the sequestering 
agents  became  saturated  and  the  resin  bound  more  nearly  its  control  per- 
centage of the Ca  45. The range of calcium concentrations over which the per- 
centage of Ca  45 bound to the resin was increasing is related both to the calcium 
stability constant and concentration of the calcium sequestering agent, though 
more to the latter than  the former.  Since it would be impossible to duplicate 
the EGTA curve by any combination of concentrations  and calcium stability 
constants very different from those used to produce the EGTA curve one may F.  N.  BRInes  AnD M.  FLEISHMAN  Soluble  Caldum-Binding Substance in Muscle  i35 
conclude  that  the  muscle  preparation  P-3  must  have  contained  a  calcium- 
binding  substance in a  concentration  of about 5.10 -5 M and characterized  as 
having a  calcium stability constant similar to that of EGTA. 
Muscle preparation  P-3  contains  both ATP  and  oxalate and  it was of in- 
terest  to  determine  if either  of these  substances  are involved  in  the  calcium 
sequestration.  Fig. 2 shows the calcium sequestering action of muscle prepara- 
tions  free of ATP,  P-2;  and  free  of ATP  and  oxalate,  P-1.  Quite  obviously 
neither  ATP  nor  oxalate  are  involved  in  the calcium  sequestering  action  of 
these soluble muscle fractions. 
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FIGURE 2.  Influence of muscle fractions free of oxalate and ATP on the binding of 
Ca  45 by chelex-100.  Curve A, solution I; curve B, solution II; curve C, muscle preparation 
P-2, curve D, muscle preparation P-1. Solution volume 5 ml, resin volume 0.26 ml. 
In  order  to  calculate  the  concentration  and  calcium  stability constant  of 
the calcium-binding substance in P-l,  P-2,  and  P-3 it was necessary to deter- 
mine the concentration and calcium stability constant of the resin chelex-100. 
This  was done with the aid of the data illustrated  in Fig.  3.  Curve B  shows 
the percentage of soluble Ca  4s in solution II when resin is absent.  This curve 
has  been used to correct for the formation  of insoluble calcium oxalate pre- 
cipitate which would otherwise be confused with the insoluble calcium resin 
complex. When applying this data to the system shown in curve A it has been 
assumed  that  the resin  bound  about  50  per  cent of the  calcium  so that  the 
concentration  of calcium  involved  in  the  formation  of calcium  oxalate  was 
only  one  half the  total  calcium  concentration.  Since  the  magnitude  of the 
calcium oxalate  precipitate  was slight  the inaccuracy of this  correction  does 136  THE  JOURNAL  OF  GENERAL  PHYSIOLOGY  • VOLUME  49  • 1965 
not  play  a  large  role  in  future  calculations.  It should  also  be  noted  that  at 
calcium  concentrations  below  1.10 .3  M no  correction  need  be  made.  Thus 
(1 O0 -- per cent soluble Ca  45) 
CaOxppt  =  Car  X  100  ( 1 ) 
where 0  x  =  oxalate, Ca r  -  total calcium concentration  and per cent soluble 
Ca  45  was  read  from curve  B  at  a  concentration  one-half that  for  which  the 
correction is to be made. 
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FIGUP~S 3.  Ca  45 binding by chelex- 
100 at different calcium concentra- 
tions.  Assay medium; 50 mM KC1, 
30  m_u  imidazole, 4  mM  MgC12, 
1 mMKoxalate, pH6.7.  CurveA, 
0.13 ml chelex-  100 in a total volume 
of  5.13 ml.  curve B, no addition 
and a total assay volume of 5.0 ml. 
Curve  A  shows  the  percentage of Ca  45 which  was  soluble  in  solution  II in 
the  presence of the resin,  chelex-100.  In this  experiment the concentration  of 
the resin was decreased by 50 per cent from that employed in the experiments 
shown  in  Figs.  1  and  2.  With  the  data  from  curve  A  the  concentration  of 
calcium-binding  sites,  R  ~,  and  the  apparent  calcium  stability  constant  K'  CaR 
were calculated,  using molar concentrations for all expressions.  The following 
equilibrium is assumed to pertain. 
MgR  -}-  Ca  2+  -t-  Mg  2+  -t-  Ox  2-  ~  CaR  -t-  CaOx  Jr-  MgOx  (2) 
The  Ca  .5 is divided as follows 
Car  =  CaR +  CaOxppt +  CaOx +  Ca  2+  (3) F.  N.  BRIGGS AND  M.  FLEISHMAN  Soluble  Calcium-Binding Substance in Muscle  137 
CaOxppt may be calculated from equation  (1) and CaOx  +  Ca  2+ from 
CaOx +  Ca  2+ =  (Car  --  CaOxppt) (per cent Ca  45 soluble) 
100  (4) 
CaR may then be calculated from equations  (I),  (3), and  (4). 
Since the binding  of calcium to  resin  displaces magnesium and  the resin 
has  been saturated with magnesium during preparation,  we may write that 
the final concentration of Mg  ~+  +  MgOx will equal the initial concentration 
of these two species plus  that magnesium released by the formation of CaR, 
the calcium-chelex-100 complex, so that 
Also 
(Mg  ~+ +  MgOx)finax =  (Mg  2+ +  MgOx)initial -}- CaR  (5) 
Oxr =  CaOxppt -t- CaOx q- MgOx -t- Ox  2- 
The stability constants for calcium and magnesium oxalate give 
(6) 
and 
MgOx  =  450  (Mg  2+) (Ox  ~-)  (7) 
CaOx  =  160 (Ca  ~+) (0x  ~-)  (8) 
The stability constant for magnesium oxalate was taken from Martell and 
Calvin  (18)  using  Simms'  data  at  #  --  0.07.  The  calcium-oxalate stability 
constant was calculated for #  =  0.07 from that given by Martell and Calvin 
for #  =  0 by use of Simms' data. 
Equations  (4)  through  (8)  were  solved  simultaneously  by  a  graphical 
method  (19)  to  give  Ca  ~+  at  each  Car  concentration.  The  results  of these 
calculations are given in Table I. 
The apparent calcium--chelex-100 stability constant 
,  CaR  (9) 
Kc.~  =  (Ca2+)(R r  _  CaR) 
contains  an  expression  for  the  total  concentration  of calcium-binding  sites 
(R~).  Since  Kca~  is  independent 3 of total  calcium concentration  and  CaR 
and  Ca  ~+ are known for various  total  calcium concentrations; Table  I,  ex- 
pression  (10) may be used to solve for R~. 
3 It is assumed that K'c~R does not change with changing Mg  2+. Evidence in support of this assump- 
tion is given in Appendix II. 138  THE  JOURNAL  OF  GENERAL  PHYSIOLOGY  • VOLUME  49  •  z965 
((Ca2+)(~  aR~  CaRj}~ =  ((Ca2+)(R~  aR~  CaR)}~  (10) 
The  subscript  i  indicates that  the values  on  this  side of equation  (10)  are 
taken at one total calcium concentration and ii  indicates that the values on 
TABLE  I 
CONCENTRATIONS  OF  COMPONENTS  OF 
SOLUTION  II  AT  VARIOUS  TOTAL  CALCIUM 
CONCENTRATIONS  (FIG.  3) 
CaT  CaOxa* ppt  CaRa  Mg~ --}- MgOx~ Ca  '~" -bCaOx4  Ca  ~+4.D'6.7's 
~M  ~M  ~M  ~M  ~M  mM 
0.05  0  0.0353  4.03  0.014  0.0128 
0.10  0  0.0717  4.07  0.028  0.0255 
0.50  0  0.357  4.37  0.14  0.129 
1.00  0  0.680  4.68  0.31  0.286 
5.00  0.16  2.69  6.69  2.15  2.06 
10.00  0.29  4.47  9.62  5.24  5.12 
* Superscripts identify the equation used. Curve B of Fig. 3 displays the data 
used for these calculations. 
TABLE  II 
CONCENTRATION  OF  CHELEX-100 
CALCIUM-BINDING  SITES  (RT) 
CaT 
i  ii  R T 
M  M 
5.10  -4  5" I0  -3  4.80-10- 3 
5.10  .4  1" 10  -3  6.35" 10  -3 
1 • 10  -3  5.10  -8  5.15-10  -8 
1.10- 3  1.10  -2  6.69.10  .3 
5.10  -3  1.10-  ~  8.07.10  -3 
Average 6.21.10  -3 
The data used for these calculations were taken from Table I. For the mean- 
ing of i  and ii see text. 
this side of the expression are taken at another total calcium concentration. 
Values for RT so obtained are given in Table II. 
The  average value of R,  was  substituted  into  equation  (9)  to  calculate 
Kc,R. The results from these calculations are given in Table III. 
Knowing the parameters R r and K~R of the resin it is possible to calculate 
both the concentration and apparent calcium stability constant of a  calcium 
sequestering agent by measuring, as done in Fig.  I, the partition of Ca  45 be- 
tween bound  and  soluble forms.  Shown below is  a  general solution  to  this F.  N.  BRIGGS AND  M.  FLEISHMAN  Soluble Calcium-Binding Substance in Muscle  139 
problem which was  applied  first to the  calculation  of the  concentration  and 
stability constant of a  known calcium chelator, EGTA  and then to the muscle 
preparations  P-l,  P-2,  and  P-3.  The  derivation  assumes  that  there  is  only 
one calcium sequestering  species.  The  success  of the  calculations  at  all  total 
calcium  concentrations  suggests  that  the  dominant  calcium  sequestering 
agent(s) are behaving as single species, though the data are equally applicable 
to a number of species with very similar stability constants. 
TABLE  III 
ESTIMATES OF THE APPARENT 
CALCIUM-CHELEX-100 STABILITY CONSTANT 
Calcium  concentration  Apparent  stability  constant,  K' 
M  M- 
5" 10  -6  4.7" 102 
1 • 10  -4  4.6" 102 
5" 10  -4  4.7" 102 
1.10-s  4.3.102 
5.10-s  3.7.102 
1.10  -3  5.3.102 
Average 4.6-102 
The data used for these calculations were taken from Tables I  and II. 
The following equilibrium describes the experimental conditions pertaining 
in Fig.  1. 
MgR  +  ATP  2- +  Ox  2-  +  X ~- +  Mg  2+  +  Ca  2+ 
MgATP +  CaATP +  MgOx  +  CaOx +  CaR +  CaX 
(11) 
where X  is any calcium-sequestering agent. 
The concentration of CaR,  the calcium chelex-100, complex is 
CaR  =  Ca,  (100  --  per cent Ca  45 not bound)  (12) 
100 
The concentration of the sequestered calcium, may be obtained from 
CaR 
CaX  =  CaT  ----  (13) 
X 
an expression derived in Appendix I. The value of f  is taken from curve A  of 
Fig.  1 and is 
f  =  100 -- per cent Ca  45100 not resin bound  ( 14 ) I4o  THE  JOURNAL  OF  GENERAL  PHYSIOLOGY  •  VOLUME  49  •  x965 
The  total  concentration  of the  calcium-sequestering  agent,  X.,  can  be cal- 
culated from an expression equivalent to equation  (10) where X  is substituted 
t 
for R  in  the expression.  The value of Kcax can  be obtained from 
rcax  =  (CaX)(KcaR)(Rr  --  CaR)  (15) 
CaR(X~  --  CaX) 
The  above  method  of calculation  has  been  tested  by  applying  it  to  the 
EGTA data in Fig.  1,  a  case in which the calculated  concentration  and  sta- 
bility constant  can  be compared  to  known  or  published  values.  The  calcu- 
lated values are shown in Table IV. The estimated value of EGTA r, 4.6. I0  -5 
TABLE  IV 
STABILITY  CONSTANT  AND 
CONCENTRATION  OF  EGTA 
(from data  in Fig.  1) 
Experiment  (]a T  CaR  GaEGTA 
M  M  M 
a  1.10  -6  2.39-10  -7  6.78.10"-  v 
b  5.10  -6  1.24.10  -6  3.33.10  -6 
e  1.10  -6  3.04.10- 6  5.90.10  -6 
d  5.10  -6  2.16.10 -6  2.09.10 -6 
e  1.10  -4  5.15-10  -6  3.05.10  -5 
f  5.10  -4  3.46-10  -4  5.33.10  -6 
g  1.10  -8  7.12.10-4  4.00.10-6 
EGTAT 
i  ii 
c  d 
C  e 
e  f 
c  g 
d  e 
d  f 
d  g 
e  f 
e  g 
f  g 
M 
3.59.10  -5 
4.13.10  -5 
6.33-10- 5 
4.07.10-5 
4.55.10  -6 
6.30.10- 6 
4.13.10- 5 
6. I0.10  -6 
4.03.10 -5 








Average  4.65.10 -5  2.8.10 s 
M,  compares  favorably  with  its  known  concentration,  4.2.10 -5  M.  The  ap- 
parent  stability  constant,  2.8.105  M  -1  is  definitely lower  than  the  literature 
values  of 6.6.105  M  -1  (20)  and  1.32.106  M  -1  (21).  The  composition  of the 
solution used in this experiment makes it difficult to use the literature  values 
for comparison.  It is  noteworthy that  the  literature  values  vary by a  factor 
of 2. 
The  stability constant  and  concentration  of calcium-binding  substance  in 
the  muscle  preparation  P-3  has  been  calculated  by  the  procedure  derived 
above.  The  results  are given  in  Table  V.  As  expected from  the  appearance 
of the  curve,  the  concentration  of calcium-binding  substance,  9.2.10 -~ M,  is 
greater  than  EGTA and  the stability constant,  1.15.10 ~ M  -I,  lower than  the 
EGTA  constant.  The  data  shown  in  Fig.  2  have  been used  to  calculate  the F.  N.  BRIGGS  AND  M.  FLEISHMAN Soluble  Caldum-Binding  Substance in Muscle  i4I 
concentration  and  stability constant  of preparations  P-2 and  P-1.  They give 
a  concentration  of 3.9.10 -5 M and  a  K'  of 1.24.10 ~ M  -1 for  P-2  and  a  con- 
centration  of  2.8.10 -5  M and  a  K'  of  2.16.105  M  -1  for  P-1.  The  calcium- 
complexing  substance from muscle  thus  appears  to have  a  calcium  stability 
constant  about  1/2  that  of EGTA  at  pH  6.7.  Its  concentration  in  muscle 
would be 4  times  greater  than  in  the  preparations  studied  since  the muscle 
substance has  been diluted  by this  factor during  its preparation.  Its  concen- 
tration in muscle would therefore,  be approximately 2.10 -4 M. 
The  chemical  nature  of the  calcium-binding  substance  has  not  been  ex- 
tensively studied to date.  It does, however, appear to be a  protein.  Thus cold 
TABLE  V 
SUMMARY  OF  CALCULATED  CONCENTRATION 
AND  CALCIUM  STABILITY  CONSTANTS  OF 
CALCIUM-COMPLEXING  SUBSTANCES 
Calcium-complexing  Calculated  apparent  stability 
system  Calculated concentration  constant 
EGTA 
M  M -I 
4.6  4-  0.4*  X10  -n  2.8  4-  0.3  X10 n 
(10)  (5) 
P-1  2.8  -4-  0.3  X10  -5  2.2  4-  0.1  X10 5 
(6)  (5) 
P-2  3.9  +  0.6  )<10  -~  1.2  4-  0.1  XI0  ~ 
(6)  (5) 
P-3  9.2  -4-  1.2  XIO  -~  1.2  4-  0.2  XIO  6 
(10)  (6) 
* Standard error of the mean,  (]~(~ --  x)2)/[N(N  --  1)];  (  )  number of ob- 
servations. 
5  per  cent  trichloracetic  acid  was  found  to  quantitatively  precipitate  the 
calcium-binding  activity.  On  the other  hand  it is  not likely to  be a  nucleic 
acid since muscle preparation P-1 when digested in hot perchloric acid yielded 
no  detectable  phosphate  when  tested  by the  King  (22)  phosphomolybdate 
method.  The molecular weight of the calcium-binding  substance is unknown 
but must  be greater  than  4000 for it was not retarded  on  a  sephadex  G-25 
column. 
Two other tissues have been examined for the presence of a calcium-binding 
substance  like  that  isolated  from  rabbit  skeletal  muscle.  When  muscle frac- 
tion P-1  was prepared  from dog myocardium a  similar calcium-binding  sub- 
stance was detected. When a fraction similar to P-1 was prepared from rabbit 
liver, using a muscle microsome preparation for the removal of contaminating ~42  THE  JOURNAL  OF  GENERAL  PHYSIOLOGY  • VOLUME  49"  x965 
calcium,  no  calcium-binding substance with activity like that  from skeletal 
muscle was detected. 
DISCUSSION 
Fuchs and Briggs (6,  14) noting that a soluble supernatant fraction of muscle 
produced relaxation in a  manner apparently identical to that produced by 
the soluble muscle-relaxing factor  (12-14)  postulated that these two types of 
preparations might produce their effects by identical mechanisms. The data 
presented in this report clearly show that this is not the case.  Fractions P-l, 
P-2, and P-3 which are similar in nature to the preparation studied by Fuchs 
and Briggs  (9)  contain a  calcium-binding substance, while the control solu- 
tion,  prepared in  a  manner identical  to  that used  to make soluble muscle- 
relaxing factor, contained no calcium-binding substance. The report of Seidel 
and Gergely (15) makes it clear that the muscle relaxation observed with the 
soluble muscle-relaxing factor is due to intrinsic lack of calcium. The soluble 
muscle supernatant fraction on the other hand could produce relaxation in 
calcium-containing systems by the sequestration of calcium. 
The  relaxing  activity  of supernatant  fractions  of muscle has  apparently 
been confirmed by Baltchefsky (10)  and by Elison  (11)  but denied in a  brief 
report by Lorand  (23).  Since few of the experimental details appear in  the 
report by Lorand it is  difficult to judge possible reasons for such a  discrep- 
ancy. The general importance of preparative procedures to the outcome may, 
however, be relevant to Lorand's results. During the preparation of a  muscle 
homogenate calcium is most likely released and would obscure the presence 
of a  calcium-binding substance unless withdrawn by  the microsome fraction 
before its  removal from the homogenate. Microsomes and  ATP  have  been 
added during the preparation of P-l,  P-2,  and P-3 to assure the removal of 
such calcium. The procedure followed by Lorand may not have made this 
possible. 
The most important consequence of the work on muscle-relaxing factors 
has been the recognition that calcium is the regulator of the activity of acto- 
myosin containing systems  and  that  such  materials  as  muscle microsomes, 
mitochondria,  and  soluble  supernatant  fractions  appear  to  exert  their  in- 
fluence upon actomyosin systems indirectly, through influences upon calcium 
concentration. To be resolved is the physiological role of each of these ma- 
terials in the regulation of muscle contraction. The theoretical guidelines for 
an answer are clear.  The substance of importance will be the one in which 
calcium binding is itself subject to regulation so that it is reversible. Evidence 
that  sarcolemma  Ca  45  flux  rates  change  during  repetitive  stimulation  of 
muscle has been presented by Bianchi and Shanes (24). These flux rates were 
insufficient, however, to allow the activation of more than a  few per cent of 
the myosin ATPase sites  (25). Recent studies by Winegrad  (26)  suggests that F.  N.  ]]RIGOS AND M.  FLEISHMAN Soluble  Calcium-Binding Substance in Muscle  i43 
there  is  a  translocation  of  intracellular  calcium  from  the  middle  of  the  I 
band into  the area of the A-I junction  as a  result of potassium-induced  con- 
tracture.  The  magnitude  of the  calcium translocation  appeared  sufficient to 
account for the activation of a  major proportion  of myosin sites. 
None  of  the  information  concerning  the  nature  of  the  calcium-binding 
protein  suggests that  its calcium stability constant  is subject to change.  The 
fact that its binding activity is independent of ATP suggests that it is a  purely 
physicochemical  activity.  What  then  is  the  physiological  relevance  of  the 
calcium-binding  protein?  Since  the  answer  to  this  question  depends  upon 
where in the cell the calcium-binding  substance is,  and  this is unknown,  it is 
only possible to outline some of the consequences which can be predicted for 
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FIctmE 4.  Influence  of the calcium-binding  substance on  the  amount  of calcium 
required  to  activate  contraction  in  the  myofibrils in  one  kg  of muscle. These  are 
theoretical curves based on assumptions given in the text. Curve A, myofibrils. Curve 
B, myofibrils in the presence of calcium-binding protein. 
a  number of different intracellular  distributions.  If the calcium-binding  sub- 
stance is derived from the sarcoplasm then  it would function  there  as a  cal- 
cium  buffer  system.  This buffer  system would  constitute  a  calcium  sink  in 
competition  with  the  myofibrils for  the  calcium  released,  presumably  from 
the  sarcotubular  system,  during  the  activation  of  contraction.  The  conse- 
quence  of this  competition  may  be  predicted  if the  concentration  and  sta- 
bility  constants  of the  calcium-binding  protein  and  myofibril  calcium  sites 
are  known.  Although  these  data  are  not  precisely known,  enough  informa- 
tion is available to allow some estimate of the effect. Fig. 4  shows the binding 
of calcium to myofibrils in the absence of calcium-binding  protein,  curve A, 
and  in the presence of calcium-binding  protein,  curve B.  These  calculations 
are  based  on  the  following  assumption:  the  concentration  of myofibril  cal- 
cium-binding  sites in muscle is 0.2 mu  (2)  and the calcium stability constant 144  THE  JOURNAL  OF  GENERAL  PHYSIOLOGY  •  VOLUME  49  "  I965 
is  2" l06 M  -1  (Fig.  1 of reference 2)  and the concentration of calcium-binding 
sites  on  the  calcium-binding  protein  is  0.2  mM  in  muscle  and  its  calcium 
stability constant is 2.106  M  -I as reported in this communication. It is quite 
apparent from Fig. 4  that the presence of the calcium-binding protein about 
doubles  the  amount  of calcium  which  must  be  released  in  order  to  fully 
activate contraction. 
The calcium-binding protein, instead of being in the sarcoplasm, might be 
associated in a  number of ways with the calcium binding or calcium uptake 
by the sarcotubule system. Thus it might play a role in the binding of calcium 
to  the vesicular membrane  (27)  or it might be  involved as  a  carrier in  the 
transport of calcium across the membrane. To rapidly drop the level of ionic 
calcium to the level required to suppress contraction would require a  carrier 
with a  substantial  binding constant for calcium.  The value of this  constant 
has  been  estimated  by Ebashi  (28)  to  be  about  4.106.  Finally,  the  protein 
might function as  an intravesicular binding site for calcium.  This would be 
of  considerable  advantage  for  the  storage  of  calcium  in  the  sarcotubular 
system, for it should  decrease the substantial  afftux rate which exists  in  the 
absence of some calcium inactivation mechanism (29). This, of course, would 
be  a  disadvantage when it  came time to  release calcium in  response  to  an 
action potential. 
A  third  possible  intracellular  origin  of  the  calcium-binding  substance 
might be  the myofibril. As mentioned earlier Weber's  (2)  data suggest that 
the myofibril calcium stability constant is  very high.  Although the  calcium 
stability  constants  for  the  various  myofibrillar  proteins  have  not  been  ex- 
tensively studied it appears that none of the known proteins possess this type 
of calcium stability  constant.  The  calcium stability  constant of myosin ap- 
pears  (30)  to be several orders of magnitude too low. The calcium bound to 
actin on the other hand is not exchangeable (31).  Tropomyosin is an attrac- 
tive candidate for the calcium-binding site  on the myofibril since a  protein 
resembling  tropomyosin  when  mixed  with  purified  actomyosin  has  been 
shown by Ebashi  (32)  to render actomyosin sensitive to control by calcium. 
Preliminary  experiments  in  our  laboratory  suggest  that  trypomyosin  does 
not have a  large calcium stability constant. Thus none of the known proteins 
of the myofibril appears  to  possess  a  calcium stability constant of sufficient 
magnitude  to  account for  the  calcium-binding activity of actomyosin.  The 
calcium-binding substance discussed in this communication comes the closest 
to having the appropriate calcium stability constant.  It is possible,  therefore, 
that the calcium-binding substance discussed here is associated with the myo- 
fibril.  On the other hand,  a  combination of proteins may give the myofibril 
its high calcium binding constant. 
Elison et  al.  (11)  have recently presented evidence which they interpret to 
indicate  that  the  relaxing effects of a  dialyzed muscle supernatant  are  not F.  N.  BRIGGS AND  M.  FLEISHMAN  Soluble  Calcium-Binding Substance in Muscle  I45 
attributable to a  calcium-binding agent therein, a  conclusion directly oppo- 
site  of ours.  Since  the  concentration of the  calcium buffer system used  by 
Elison was 2.5.10 -4 M, or higher, it is possible that the presence of a  calcium- 
binding substance at a  concentration of 5.10 -s M, as measured in our super- 
natant,  might not  have  been  detected.  Furthermore,  the  data  which  they 
present in favor of the hypothesis that a  supernatant fraction of muscle pro- 
duces  relaxation without changing the level of ionic calcium are  subject to 
the criticism that the experiments were carried out with glycerinated muscle 
bundles rather than single fibers (25).  That this criticism may be valid is sug- 
gested by the slight relaxation,  27  per  cent, observed  by Elison at an ionic 
calcium concentration of  1.10 -7  M,  a  relaxation which is  much lower than 
that observed by Weber and Herz (2) and Seidel and Gergely (3) at the same 
levels of ionic calcium. Briggs and Portzehl  (25)  observed that fiber bundles 
such as used by Elison do not relax normally unless a  transphosphorylation 
system is added.  Since myokinase would be a  constituent of a  muscle super- 
natant preparation its  addition in Elison's study may have merely revealed 
the expected relaxation rather than causing relaxation. 
Appendix I 
Examination of curve A of Fig.  1 shows that over the range of calcium concentrations 
studied the calcium resin concentration, CaR, is a nearly constant percentage of the 
total calcium concentration, Car i.e., 
CaR 
Car  -  f  ( 16 ) 
Under the conditions prevailing for curve A, we may write the following expression 
which says that the total calcium concentration is equal to the sum of the various 
calcium-containing substances  plus ionic calcium, 
Car  =  CaR +  CaATP -t-  CaOx  -t-  Ca  2+  (17) 
We may then define the following stability constants: 
CaR  .  Ca~+_  (CAR) 
K1  -  (Ca2+)(R2_) ,  (K1)(R2_)  (18) 
CaATP 
Ks  =  (Ca2+)(ATP2_) ;  CaATP  =  K2(Ca2+)(ATP 2-)  (19) 
CaOx  . 
Ka  -  (Ca~+)(Ox2_),  CaOx  =  K3(Ca  2+) (Ox  2-)  (20) 
substituting expressions  (19) and (20) into expression  (I 7) one may write 
Car  =  CaR  +  Ca  2+  {(K~(ATP  ~-)  -t-  K3(Ox 2-)  -]-  l}  (21) x46  THE  JOURNAL  OF  GENERAL  PHYSIOLOGY  •  VOLUME  49  "  1965 
substituting expression (18) for Ca  ~+ 
CaT  =  CaR +  -- 
rearranging terms 
CaR 
KI(R  2-) 
{  (K2(ATP  ~-)  +  K3(Ox  2-)  +  1 }  (22) 
CaR  KI(R  2-) 
Car  K~(R  2-)  +  K2(ATP  2-)  -t- K3(Ox  2-)  --  1  (23) 
Thus, 
KI(R  ~-) 
f  =  (24)  Kt(R  2-)  -4-K2(ATP 2-)  +  K3(Ox  2-)  -{-  1 
This expression will remain nearly constant, as it does in curve C, as long as R ~-, 
ATP  2-,  and  Ox  2- are changing very little. This condition is met as long as the cal- 
cium concentration is low. 
If now a  calcium-binding agent X  is present,  equation  17 may be rewritten 
CaT =  CaR +  CaX +  CaATP +  CaOx  +  Ca  2+  (25) 
or 
CaT --  CaX ----- CaR q-  CaATP q-  CaOx  q-  Ca  2+  (26) 
The right side of equation (26)  is equal to the right side of equation (17). Therefore, 
CaR  Xl(R  2-) 
CaT  -  Ca X  KI(R  2-)  -Jr-K2(ATP 2-)  q-K3(Ox  2-)  --}- 1 
The right side of equation (27) is equal to equation (23). Therefore, 
(27) 
CaR 
CaT --  Ca X  -  ]  (28) 
or 
CaR 
CaX  =  CaT  ----  (29)  ] 
Appendix  II 
It is assumed in equation  (10)  and in other parts of this article that KcaR does not 
change with changing values of Mg  2+. By comparing theoretical and observed ratios 
of CaR/CaT for the experiments reported in Figs. 1 and 2, which represent conditions F.  N.  BRIOGS AND M.  FLEISHMAN Soluble  Calcium-Binding Substance in Muscle  147 
with  widely different  Mg  2+,  the  essential  constancy of K'  can  under  these  conditions 
can be verified. 
Under  the  conditions  depicted  for curve A  of Fig.  2  the value  of Mg  ~+ is 4  raM. 
The  theoretical  value  of the  ratio  CaR/Car  for this  curve  may be  calculated  from 
the following equation : 
CaR  KI(R  ~-) 
-  (30) 
Car  KI(R  2-)  +  1 
For  the  meaning  of symbols  and  the  derivation  of this  equation,  see  Appendix  I. 
Since//'1  =  4.6. l0  s M  "-1 (Table  III) and  A  n-  =  2  X  6.21.10-n  M (Table  II), at 
low calcium concentrations, the theoretical value of CaR/Car  =  0.85. The observed 
value of the ratio, 0.81, is in reasonable agreement with the theoretical value. 
Fig.  1 represents  a  condition  where  Mg  ~+  is  greatly reduced  below  the  value  of 
4  mM.  In these  experiments  ATP was 4  mM and  oxalate  1 mM; since  both  of these 
substances  bind  Mg  2+  its  concentration  would  be  very  small.  It  is,  therefore,  im- 
portant to see how this affects the value of Kc,a. 
For curve A, Fig.  1, 
CaR  K~  (  R ~-) 
-  (31) 
Car  K~(R  2-)  +  K2(ATP  ~-)  +  K3(Ox 2-) +  1 
For low values of Car, R~-  =  1.24.10-  ~ M.  If Kc~R is not substantially  altered  by the 
large reduction of Mg  ~+ then K1  =  4.6.102  M-L The value of Ks may be calculated 
from the following: 
True Ke,ATe  =  K2[1  +  (H)(Ku)  +  (Mg)(KMg)  +  K+(K~+)]  (32) 
True K'C~,ATP =  9.4- 103 M  -I, reference  (33). 
H  =  2" 10-7 M 
/~H 
Mg 
=  3.2- 106 M  -I, reference  (18). 
=  4.10-3 M 
KM g  =  1.66" 104 M  -1, reference  (33). 
K +  =  5.10-  2 M 
/G+  =  1.1.10' M  -1, reference  (33). 
Substituting  these  values  into  equation  (32)  K2  =  1.36.102,  Since  ATp2- = 
4.10  -3 ~,  K3  =  1.6.102,  and  Ox  ~-  =  1.10  -3 u,  CaR/Car  =  0.77.  This  compares 
favorably with the observed value 0.74. Thus Kcan does not appear to be significantly I48  THE  JOURNAL  OF  GENERAL  PHYSIOLOGY  •  VOLUME  49  "  I965 
dependent  upon  Mg  ~+  over  the  range  of values  encountered  in  the  experiments 
reported in this paper. 
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